Recorded on February 23, 2021
In recognition of March being Myeloma Awareness Month, The Leukemia & Lymphoma Society is pleased to share this informative podcast episode on updates and advancements in multiple myeloma. Healthcare professionals are challenged to stay up-to-date on new and emerging treatments options, including updates in immunotherapy, and to incorporate these treatment approaches into decision making. Dr. Edward Stadtmauer, from The University of Pennsylvania, shares his insights into these topics, as well as discusses myeloma in underserved communities, treatment in the time of the COVID-19 pandemic, and exciting advances in multiple myeloma.
Edward A. Stadtmauer, MD
Section Chief of Hematologic Malignancies
Roseman, Tarte, Harrow, and Shaffer Families’ President’s Distinguished Professor
Hematology-Oncology Division
Perelman Center for Advanced Medicine
The University of Pennsylvania
Philadelphia, PA
Section Chief of Hematologic Malignancies
Roseman, Tarte, Harrow, and Shaffer Families’ President’s Distinguished Professor
Hematology-Oncology Division
Perelman Center for Advanced Medicine
The University of Pennsylvania
Philadelphia, PA
Podcast: Play in new window | Download (Duration: 35:03 — 32.1MB)